Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,737 INR | -0.12% | -1.51% | -9.75% |
Apr. 08 | Nicomac Machinery and RP Advisory Services Reportedly Likely to Sell 4.4% Stake in Gland Pharma via Block Deals | CI |
Apr. 08 | Gland Pharma Gets US FDA Approval for Eribulin Mesylate Injection | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.75% | 3.44B | |
+24.17% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.45% | 233B | |
+6.04% | 201B | |
-10.51% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- GLAND Stock
- News Gland Pharma Limited
- Nomura Adjusts Gland Pharma’s Price Target to 2,362 Indian Rupees From 3,809 Indian Rupees, Keeps at Neutral